Live tape
Top 8, mentions 7d8,614GOOGL1,722 mentions▲ +0.04SNDK1,435 mentions▲ +0.11NVDA1,051 mentions▲ +0.08SPCX1,035 mentions▲ +0.08META989 mentions▲ +0.03NBIS836 mentions▲ +0.09HTZ818 mentions▲ +0.09MSFT728 mentions▲ +0.05

Equity · Healthcare

FTRE

Fortrea Holdings Inc. · NasdaqGS

$18 0.00% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 39 sessions
$20 $12 21 May 17 Jul

The line runs $13.13 on 21 May through $18 on 17 July, on a scale from $12 to $20. Days the market did not trade hold the previous close, flat.

The chart above plots the price of FTRE over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 39 sessions over that window: $13.13 on 21 May 2026 through $18 on 17 July 2026.

Market cap $1.7B
52-week range $4.66 – $18.40
Avg volume 282.8K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026

FTRE insider trades

SEC Form 4 · last 90 days · newest reported trade 6 Aug 2026
Open-market buys 0
Open-market sells 6
Net sold $4.34M
Non-trade filings 10
Date Insider Type Shares Value
06 Aug 2026 Thakral Anshul Chief Executive Officer Sell 111,857 $2.03M
05 Aug 2026 Thakral Anshul Chief Executive Officer Sell 99,869 $1.91M
03 Aug 2026 SANDERS MACHELLE Director Sell 9,700 $175K
10 Jun 2026 Morais Mark A. Chief Operating Officer Sell 4,674 $79K
02 Jun 2026 Mcconnell Jill G. Chief Financial Officer Sell 4,866 $75K
02 Jun 2026 Morais Mark A. Chief Operating Officer Sell 4,866 $75K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
04 Aug 2026 Thakral Anshul Chief Executive Officer Option exercise 416,666
20 Jul 2026 Smith David Ross Director Option exercise 6,598
10 Jun 2026 Russell Erin L Director Option exercise 38,817
10 Jun 2026 Ray Amrit Director Option exercise 38,817
10 Jun 2026 Pesicka Edward A Director Option exercise 38,817
10 Jun 2026 Smith David Ross Director Option exercise 38,817
10 Jun 2026 Smith David Ross Director Tax withheld 18,244 $298K
10 Jun 2026 SANDERS MACHELLE Director Option exercise 38,817
01 Jun 2026 Mcconnell Jill G. Chief Financial Officer Option exercise 11,006
01 Jun 2026 Morais Mark A. Chief Operating Officer Option exercise 11,006

FTRE reported financials

SEC EDGAR XBRL

FTRE reported revenue of $2.7B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$986.2M.

Figure Reported Period
Revenue $2.7B 31 Dec 2025 fiscal year
Net income −$986.2M 31 Dec 2025 fiscal year
Diluted EPS −$10.81 31 Dec 2025 fiscal year
Total assets $2.7B 30 Jun 2026 at period end
Total equity $524.2M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

FTRE earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.14 $678M
31 Mar 2026 Q1 2026 $-0.25 $637M
31 Dec 2025 FY 2025 $-10.81 $2.72B
30 Sep 2025 Q3 2025 $-0.17 $701M
30 Jun 2025 Q2 2025 $-4.14 $710M
31 Mar 2025 Q1 2025 $-6.25 $651M
31 Dec 2024 FY 2024 $-3.67 $2.70B
30 Sep 2024 Q3 2024 $-0.31 $675M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

FTRE institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a FTRE position for the quarter ended 30 Jun 2026 — a combined $165.1M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Corvex Management Trimmed −35.6% shares 2,988,551 $52.0M
AQR Capital Management Held (±25%) −9.6% shares 2,980,474 $51.9M
Renaissance Technologies Held (±25%) −10.0% shares 1,289,609 $22.4M
Citadel Advisors Added +100.8% shares 1,023,010 $17.8M
Millennium Management Added +148.0% shares 626,489 $10.9M
Two Sigma Investments Trimmed −52.2% shares 215,937 $3.8M
D. E. Shaw & Co. Added +139.7% shares 127,123 $2.2M
Man Group Added +31.7% shares 94,621 $1.6M
Marshall Wace Trimmed −72.0% shares 82,638 $1.4M
Tudor Investment Corp New position 57,695 $1.0M

Source: SEC EDGAR 13F filings

FTRE fails-to-deliver

SEC CNS data

On 24 Jul 2026, 2 shares of FTRE failed to deliver (about $39).

Settlement date Shares failed Notional % of shares out
24 Jul 2026 2 $39 <0.001%
16 Jul 2026 114 $2K <0.001%

Source: SEC fails-to-deliver (CNS) data